Mounting pressure from healthcare providers to reduce the overall cost of healthcare service delivery has resulted in medical device firms increasingly looking towards efficiency and reduction of costs associated with sourcing materials and component parts for medical technologies. Executives responsible for strategic sourcing of materials and components have, as a result, taken a variety of steps to streamline operating costs, leveraging new procurement technologies and strategies to marginalize costs while mitigating the risks of utilizing lower cost components. As pressure to reduce costs continues to play a pivotal factor for medical device strategic sourcing teams, gathering for the 2nd Annual Medical Device Strategic Sourcing Conference will provide teams with an opportunity to gather to discuss and debate not only the challenges faced but also practical strategies for maintaining the highest level of product quality at a reduced cost through unparalleled sourcing tactics.

Throughout the medical device industry, corporations are continually looking to reduce the overall cost of producing high-quality medical devices, and look towards quality assurance executives to mitigate risk and maintain pristine levels of quality all while reducing expenditures. At the same time, the FDA along with other global regulatory agencies are increasing the level of regulatory scrutiny alongside increased numbers of audits, inspections and resulting warning letters, setting industry executives unclear on how to best maintain compliance. Through a conference program designed to provide insight and clarity into leading corporations, the Q1 Medical Device Quality Assurance program will provide executives with an unrivaled educational and networking platform.